Skip to content

Evaluation of an Iris Dilatation Ring in Cataract Surgery (ADICC-ID)

Evaluation of an Iris Dilatation Ring in Cataract Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02434588
Acronym
ADICC-ID
Enrollment
25
Registered
2015-05-05
Start date
2015-04-14
Completion date
2018-07-31
Last updated
2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Pupil

Brief summary

During cataract surgery, it is necessary to dilate the iris in order to remove the crystalline lens and position the implant. The diameter of the optical implant being 6 mm, in case of capsulorhexis crystalline access 5.5 mm, the expansion should be at least 6 mm. At pre-operative consultation, the iris is always dilated by instillation of eye drops and measured at the slitlamp. For patients with an inadequate dilation, the intervention requires the use of a mechanical dilatation device. This study aims to assess the value of an alternative dilatation ring to Malyugin ring, which can be inserted and removed through an incision of less than 2 mm in diameter, due to its size smaller than that of the Malyugin ring. Our hypothesis is that this Bhattacharjee ring ensures sufficient and stable iris dilation during surgery, enabling implant placement in good conditions.

Interventions

DEVICEBhattacharjee ring

Insertion of a Bhattacharjee ring to stabilise the pupil during cataract surgery

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with programmed cataract surgery under topical or local anesthesia * Need to use a dilatation ring during operation, highlighted by iris dilatation ≤ 6 mm on slitlamp, after mydriatic solution and 10% phenylephrine eye drops instillation

Exclusion criteria

* Pregnant or breastfeeding woman * Patient's refusal to participate in the study * Patient non covered by health insurance * Complete iridectomy * Tearing of iris sphincter * Important posterior synechiae (when the iris is attached to the anterior surface of the implant) * Anterior chamber very deep (depth of the anterior chamber lower than 1mm after injection of the viscous product)

Design outcomes

Primary

MeasureTime frame
Proportion of patients with dilated iris ≥ 6 mmImmediately after ring insertion

Secondary

MeasureTime frame
Proportion of patients with dilated iris ≥ 6 mm after instillation of dilating eye dropsImmediately before ring insertion
Proportion of patients with ≥ 6mm iris dilation after surgeryJust before ring removal
Proportion of patients with iris retraction ≤ 4 mm immediatelyImmediatly after ring removal
Surgeon feeling operational conditions on an visual analogic scaleImmediatly after ring insertion
Change for Malyugin ring during surgeryJust before ring insertion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026